Global Post herpetic Neuralgia Treatment Market Growth (Status and Outlook) 2025-2031

Global Post herpetic Neuralgia Treatment Market Growth (Status and Outlook) 2025-2031

The global Post herpetic Neuralgia Treatment market size is predicted to grow from US$ 1677 million in 2025 to US$ 2140 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.

North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.

In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.

LPI (LP Information)' newest research report, the “Post herpetic Neuralgia Treatment Industry Forecast” looks at past sales and reviews total world Post herpetic Neuralgia Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Post herpetic Neuralgia Treatment sales for 2025 through 2031. With Post herpetic Neuralgia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post herpetic Neuralgia Treatment industry.

This Insight Report provides a comprehensive analysis of the global Post herpetic Neuralgia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Post herpetic Neuralgia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post herpetic Neuralgia Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post herpetic Neuralgia Treatment and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post herpetic Neuralgia Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Post herpetic Neuralgia Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Anticonvulsants
Skin Patch
Other

Segmentation by Distribution Channel:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine

Please note: The report will take approximately 2 business days to prepare and deliver.